Cargando…
Venom peptides in association with standard drugs: a novel strategy for combating antibiotic resistance - an overview
Development of antibiotic resistance that leads to resurgence of bacterial infections poses a threat to disease-free existence for humankind and is a challenge for the welfare of the society at large. Despite research efforts directed towards treatment of pathogens, antibiotics within new improved c...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centro de Estudos de Venenos e Animais Peçonhentos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7416788/ https://www.ncbi.nlm.nih.gov/pubmed/32843888 http://dx.doi.org/10.1590/1678-9199-JVATITD-2020-0001 |
_version_ | 1783569362438848512 |
---|---|
author | Lamiyan, Ashish K. Dalal, Ramkesh Kumar, Neelima R. |
author_facet | Lamiyan, Ashish K. Dalal, Ramkesh Kumar, Neelima R. |
author_sort | Lamiyan, Ashish K. |
collection | PubMed |
description | Development of antibiotic resistance that leads to resurgence of bacterial infections poses a threat to disease-free existence for humankind and is a challenge for the welfare of the society at large. Despite research efforts directed towards treatment of pathogens, antibiotics within new improved classes have not emerged for years, a fact largely attributable to the pharmacological necessities compelling drug development. Recent reversion to the use of natural products alone or in combination with standard drugs has opened up new vistas for alternative therapeutics. The success of this strategy is evident in the sudden interest in plant extracts as additives/synergists for treatment of maladies caused by drug-resistant bacterial strains. Animal venoms have long fascinated scientists as sources of pharmacologically active components that can be exploited for the treatment of specific ailments and should be promoted further to clinical trials. In the present review, we outline the scope and possible methods for the applications of animal venoms in combination with commercial antibiotics to offer a better treatment approach against antibiotic-resistant infections. |
format | Online Article Text |
id | pubmed-7416788 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Centro de Estudos de Venenos e Animais Peçonhentos |
record_format | MEDLINE/PubMed |
spelling | pubmed-74167882020-08-24 Venom peptides in association with standard drugs: a novel strategy for combating antibiotic resistance - an overview Lamiyan, Ashish K. Dalal, Ramkesh Kumar, Neelima R. J Venom Anim Toxins Incl Trop Dis Review Development of antibiotic resistance that leads to resurgence of bacterial infections poses a threat to disease-free existence for humankind and is a challenge for the welfare of the society at large. Despite research efforts directed towards treatment of pathogens, antibiotics within new improved classes have not emerged for years, a fact largely attributable to the pharmacological necessities compelling drug development. Recent reversion to the use of natural products alone or in combination with standard drugs has opened up new vistas for alternative therapeutics. The success of this strategy is evident in the sudden interest in plant extracts as additives/synergists for treatment of maladies caused by drug-resistant bacterial strains. Animal venoms have long fascinated scientists as sources of pharmacologically active components that can be exploited for the treatment of specific ailments and should be promoted further to clinical trials. In the present review, we outline the scope and possible methods for the applications of animal venoms in combination with commercial antibiotics to offer a better treatment approach against antibiotic-resistant infections. Centro de Estudos de Venenos e Animais Peçonhentos 2020-08-10 /pmc/articles/PMC7416788/ /pubmed/32843888 http://dx.doi.org/10.1590/1678-9199-JVATITD-2020-0001 Text en This article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Review Lamiyan, Ashish K. Dalal, Ramkesh Kumar, Neelima R. Venom peptides in association with standard drugs: a novel strategy for combating antibiotic resistance - an overview |
title | Venom peptides in association with standard drugs: a novel strategy
for combating antibiotic resistance - an overview |
title_full | Venom peptides in association with standard drugs: a novel strategy
for combating antibiotic resistance - an overview |
title_fullStr | Venom peptides in association with standard drugs: a novel strategy
for combating antibiotic resistance - an overview |
title_full_unstemmed | Venom peptides in association with standard drugs: a novel strategy
for combating antibiotic resistance - an overview |
title_short | Venom peptides in association with standard drugs: a novel strategy
for combating antibiotic resistance - an overview |
title_sort | venom peptides in association with standard drugs: a novel strategy
for combating antibiotic resistance - an overview |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7416788/ https://www.ncbi.nlm.nih.gov/pubmed/32843888 http://dx.doi.org/10.1590/1678-9199-JVATITD-2020-0001 |
work_keys_str_mv | AT lamiyanashishk venompeptidesinassociationwithstandarddrugsanovelstrategyforcombatingantibioticresistanceanoverview AT dalalramkesh venompeptidesinassociationwithstandarddrugsanovelstrategyforcombatingantibioticresistanceanoverview AT kumarneelimar venompeptidesinassociationwithstandarddrugsanovelstrategyforcombatingantibioticresistanceanoverview |